Диссертация (1174193), страница 24
Текст из файла (страница 24)
575261.95.Cui, D. Gli1 is a potential target for alleviating multidrug resistance of gliomas / D. Cui, Q. Xu,K. Wang, X. Che // J Neurol Sci. – 2010. – Vol. 288. – № 1-2. – P. 156-66.96.Phillips, H. S. Molecular subclasses of high-grade glioma predict prognosis, delineate a patternof disease progression, and resemble stages in neurogenesis / H. S. Phillips, S. Kharbanda, R.Chen et al. // Cancer Cell.
– 2006. – Vol. 9. – № 3. – P. 157-73.97.Braun, S. Hedgehog signaling in glioblastoma multiforme / S. Braun, H. Oppermann, A. Muelleret al. // Cancer Biol Ther. – 2012. – Vol. 13. – № 7. – P. 487-95.98.Becher, O. J. Gli activity correlates with tumor grade in platelet-derived growth factor-inducedgliomas / O. J. Becher, D. Hambardzumyan, E. I.
Fomchenko et al. // Cancer Res. – 2008. – Vol.68. – № 7. – P. 2241-9.99.Sasai, K. Shh pathway activity is down-regulated in cultured medulloblastoma cells: implicationsfor preclinical studies / K. Sasai, J. T. Romer, Y. Lee et al. // Cancer Res. – 2006. – Vol. 66. – №8. – P. 4215-22.100. Ulasov, I. V. Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity ofCD133(+) glioma stem cells to temozolomide therapy / I. V. Ulasov, S. Nandi, M. Dey et al.
//Mol Med. – 2011. – Vol. 17. – № 1-2. – P. 103-12.101. Takezaki, T. Essential role of the Hedgehog signaling pathway in human glioma-initiating cells /T. Takezaki, T. Hide, H. Takanaga et al. // Cancer Sci. – 2011. – Vol. 102. – № 7. – P. 1306-12.102. Uchida, H.
Role of sonic hedgehog signaling in migration of cell lines established from CD133positive malignant glioma cells / H. Uchida, K. Arita, S. Yunoue et al. // J Neurooncol. – 2011. –Vol. 104. – № 3. – P. 697-704.103. Sarangi, A. Targeted inhibition of the Hedgehog pathway in established malignant gliomaxenografts enhances survival / A. Sarangi, J. G. Valadez, S. Rush et al. // Oncogene. – 2009.
–Vol. 28. – № 39. – P. 3468-76.104. Abiria, S. A. Expression of Hedgehog ligand and signal transduction components in mutuallydistinct isocitrate dehydrogenase mutant glioma cells supports a role for paracrine signaling / S.A. Abiria, T.
V. Williams, A. L. Munden et al. // J Neurooncol. – 2014. – Vol. 119. – № 2. – P.243-251.110105. Yan, G. N. Glioma stem cells enhance endothelial cell migration and proliferation via theHedgehog pathway / G. N. Yan, Y. F. Lv, L. Yang et al. // Oncol Lett. – 2013. – Vol. 6. – № 5. –P.
1524-1530.106. Yan, G. N. Endothelial cells promote stem-like phenotype of glioma cells through activating theHedgehog pathway / G. N. Yan, L. Yang, Y. F. Lv et al. // J Pathol. – 2014. – Vol. 234. – № 1. –P. 11-22.107. Yang, L. Activation of the hedgehog-signaling pathway in human cancer and the clinicalimplications / L. Yang, G.
Xie, Q. Fan et al. // Oncogene. – 2010. – Vol. 29. – № 4. – P. 469-81.108. Rimkus, T. K. Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened andGLI Inhibitors / T. K. Rimkus, R. L. Carpenter, S. Qasem et al. // Cancers (Basel). – 2016. – Vol.8. – № 2.109. Incardona, J. P. The teratogenic Veratrum alkaloid cyclopamine inhibits sonic hedgehog signaltransduction / J.
P. Incardona, W. Gaffield, R. P. Kapur et al. // Development. – 1998. – Vol.125. – № 18. – P. 3553-62.110. Sanchez, P. In vivo inhibition of endogenous brain tumors through systemic interference ofHedgehog signaling in mice / P. Sanchez, A. Ruiz i Altaba // Mech Dev. – 2005. – Vol. 122. – №2. – P. 223-30.111. Karhadkar, S. S. Hedgehog signalling in prostate regeneration, neoplasia and metastasis / S. S.Karhadkar, G. S. Bova, N. Abdallah et al.
// Nature. – 2004. – Vol. 431. – № 7009. – P. 707-12.112. Feldmann, G. Blockade of hedgehog signaling inhibits pancreatic cancer invasion andmetastases: a new paradigm for combination therapy in solid cancers / G. Feldmann, S. Dhara,V. Fendrich et al. // Cancer Res. – 2007. – Vol. 67. – № 5. – P. 2187-96.113. Hirotsu, M. Smoothened as a new therapeutic target for human osteosarcoma / M. Hirotsu, T.Setoguchi, H. Sasaki et al. // Mol Cancer.
– 2010. – Vol. 9. – № 5.114. Zhang, J. Synthesis and anticancer activity studies of cyclopamine derivatives / J. Zhang, M.Garrossian, D. Gardner et al. // Bioorg Med Chem Lett. – 2008. – Vol. 18. – № 4. – P. 1359-63.115. Kumar, S. K. Targeted inhibition of hedgehog signaling by cyclopamine prodrugs for advancedprostate cancer / S. K. Kumar, I. Roy, R. K. Anchoori et al.
// Bioorg Med Chem. – 2008. – Vol.16. – № 6. – P. 2764-8.116. Sekulic, A. Efficacy and safety of vismodegib in advanced basal-cell carcinoma / A. Sekulic, M.R. Migden, A. E. Oro et al. // N Engl J Med. – 2012. – Vol. 366. – № 23. – P. 2171-9.117. Yauch, R. L. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor inmedulloblastoma / R. L. Yauch, G. J. Dijkgraaf, B. Alicke et al. // Science. – 2009.
– Vol. 326. –№ 5952. – P. 572-4.111118. Metcalfe, C. Hedgehog fights back: mechanisms of acquired resistance against Smoothenedantagonists / C. Metcalfe, F. J. de Sauvage // Cancer Res. – 2011. – Vol. 71. – № 15. – P. 505761.119. Hoch, L. MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in thetransmembrane domain of the Smoothened receptor / L. Hoch, H. Faure, H. Roudaut et al. //FASEB J. – 2015.
– Vol. 29. – № 5. – P. 1817-29.120. Chen, Q. Down-regulation of Gli transcription factor leads to the inhibition of migration andinvasion of ovarian cancer cells via integrin beta4-mediated FAK signaling / Q. Chen, R. Xu, C.Zeng et al. // PLoS One. – 2014. – Vol. 9. – № 2. – P. e88386.121. Srivastava,R.K.GLIinhibitorGANT-61diminishesembryonalandalveolarrhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis / R. K.
Srivastava, S. Z. Kaylani,N. Edrees et al. // Oncotarget. – 2014. – Vol. 5. – № 23. – P. 12151-65.122. Wickstrom, M. Targeting the hedgehog signal transduction pathway at the level of GLI inhibitsneuroblastoma cell growth in vitro and in vivo / M.
Wickstrom, C. Dyberg, T. Shimokawa et al.// Int J Cancer. – 2013. – Vol. 132. – № 7. – P. 1516-24.123. List, A. Opportunities for Trisenox (arsenic trioxide) in the treatment of myelodysplasticsyndromes / A. List, M. Beran, J. DiPersio et al. // Leukemia. – 2003. – Vol. 17. – № 8. – P.1499-507.124. Coon, V. Molecular therapy targeting Sonic hedgehog and hepatocyte growth factor signaling ina mouse model of medulloblastoma / V. Coon, T. Laukert, C. A. Pedone et al.
// Mol CancerTher. – 2010. – Vol. 9. – № 9. – P. 2627-36.125. Petrova, E. Hedgehog acyltransferase as a target in pancreatic ductal adenocarcinoma / E.Petrova, A. Matevossian, M. D. Resh // Oncogene. – 2015. – Vol. 34. – № 2. – P. 263-8.126. Marini, K. D. Mechanisms of Hedgehog signalling in cancer / K. D. Marini, B. J. Payne, D. N.Watkins et al. // Growth Factors. – 2011. – Vol.
29. – № 6. – P. 221-34.127. Hanahan, D. The hallmarks of cancer / D. Hanahan, R. A. Weinberg // Cell. – 2000. – Vol. 100.– № 1. – P. 57-70.128. Hanahan, D. Hallmarks of cancer: the next generation / D. Hanahan, R. A. Weinberg // Cell. –2011. – Vol.
144. – № 5. – P. 646-74.129. Dahmane, N. The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis/ N. Dahmane, P. Sanchez, Y. Gitton et al. // Development. – 2001. – Vol. 128. – № 24. – P.5201-12.130. Hynes, M. Control of cell pattern in the neural tube by the zinc finger transcription factor andoncogene Gli-1 / M. Hynes, D. M. Stone, M. Dowd et al. // Neuron. – 1997. – Vol. 19. – № 1. –P. 15-26.112131. Li, X. Snail induction is an early response to Gli1 that determines the efficiency of epithelialtransformation / X.
Li, W. Deng, C. D. Nail et al. // Oncogene. – 2006. – Vol. 25. – № 4. – P.609-21.132. Fiaschi, M. Development of mammary tumors by conditional expression of GLI1 / M. Fiaschi,B. Rozell, A. Bergstrom et al. // Cancer Res. – 2009. – Vol. 69. – № 11. – P. 4810-7.133. Thomas, Z. I. Targeting GLI1 expression in human inflammatory breast cancer cells enhancesapoptosis and attenuates migration / Z. I. Thomas, W. Gibson, J. Z.
Sexton et al. // Br J Cancer. –2011. – Vol. 104. – № 10. – P. 1575-86.134. Lee, S. J. Sonic hedgehog-induced histone deacetylase activation is required for cerebellargranule precursor hyperplasia in medulloblastoma / S. J. Lee, S. Lindsey, B. Graves et al. //PLoS One. – 2013. – Vol. 8. – № 8. – P. e71455.135. Mille, F. The Shh receptor Boc promotes progression of early medulloblastoma to advancedtumors / F. Mille, L.
Tamayo-Orrego, M. Levesque et al. // Dev Cell. – 2014. – Vol. 31. – № 1. –P. 34-47.136. Wilkinson, S. E. Hedgehog signaling is active in human prostate cancer stroma and regulatesproliferation and differentiation of adjacent epithelium / S. E. Wilkinson, L. Furic, G. Buchananet al. // Prostate. – 2013. – Vol. 73. – № 16. – P. 1810-23.137. Singh, B. N.
Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancerstem cell characteristics: molecular mechanisms / B. N. Singh, J. Fu, R. K. Srivastava et al. //PLoS One. – 2011. – Vol. 6. – № 11. – P. e27306.138. Hao, K. Hedgehog signaling pathway regulates human pancreatic cancer cell proliferation andmetastasis / K. Hao, X. D. Tian, C. F. Qin et al. // Oncol Rep. – 2013. – Vol. 29. – № 3. – P.1124-32.139. Lee, J.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
